Predictors of Fall-Related Injuries in Fallers—A Study in Persons with Cognitive Impairment
Abstract
1. Introduction
2. Materials and Methods
2.1. Data Material
2.2. Variables
2.2.1. Person Characteristics
- Sex (male/female); Age (years); Height (cm); Body weight (kg); Body Mass Index (BMI: kg/m2).
- Injured person: A person admitted to the hospital after a fall.
- Education (years in formal education).
- Living alone at home (yes/no).
- In need of regular public health service (yes/no).
- In need of walking assistance: no; indoor or outdoor; indoor and outdoor (scores 0–2).
- Physical activity was the sum of easy and strenuous activity (score 0–8).
- Systolic and diastolic blood pressure (mmHg) and heart rate (beats/min) were measured while sitting and in the standing position for 1 and 3 min.
2.2.2. Medical History, Cognitive Functions
- Ten diseases, present or previous, were noted (yes/no): Cerebrovascular disease, Parkinson’s disease, Neurological disease, Coronary heart disease, Cardiac surgery, Diabetes, Cancer, Chronic obstructive pulmonary disease (COPD), Polyarthritis, and Depression (present).
- Cornell scale for measuring depression in dementia (Score 0–38. No depression < 7; mild depression 7–11; moderate–severe depression ≥ 12) [14].
- MAYO Sleep questionnaire. Question 8 of the questionnaire rates the person’s general level of alertness from sleeping to normally awake during the day (score 0–10) [15].
- MAYO composite fluctuation scale (Score 0–4. Dichotomized: normal 0–2 = 0; abnormal 3–4 = 1) [16]
- Duration of cognitive impairment assessed by the participant or next of kin (years).
- CERAD word list. The test measures both immediate and delayed recall (after 10 min) of 10 words. The immediate test was the sum of three recalls. The word list was a demographically adjusted version of the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [19,20,21]. Higher scores mean better performance.
- Trail Making Tests A and B (TMT-A and TMT-B). The tests measure mental flexibility (the results are given in seconds). A shorter time (lower scores) indicates better performance.
- Drugs (number of drugs taken regularly).
2.2.3. Laboratory Tests
- Blood tests: Hb (g/100 mL); CRP (mg/L); ESR (mm/1h); Thrombocytes (109/L); Creatinine (µmol/L); Albumin (g/L); Folic acid (nmol/L); Cholesterol (mmol/L); Homocystein (µmol/L); Na (mmol/L); K (mmol/L); Ca (mmol/L); Thyroxin (pmol/L); TSH (mU/L); Vitamin B12 (pmol/L); Vitamin D (nmol/L); HbA1c (nmol/mol); Methyl Malonic Acid (MMA: µmol/L); ALAT (U/L); Gamma-GT (U/L); ALP (U/L).
- Cerebrospinal fluid: Phospho-tau (reference value < 80 pg/mL); Total-tau (reference values: age < 50: <300 pg/mL; age 50–70: <450 pg/mL; age > 70: <500 pg/mL); Beta-amyloid (reference value < 550 ng/L) [22].
- Genes: APOE genotypes: E2E2; E2E3; E2E4; E3E3: E3E4; E4E4.
2.2.4. Clinical Evaluation and Diagnoses
- Dementia diagnoses: Alzheimer’s Disease (AD), Mixed AD/Vascular Dementia (AD/VaD), Vascular Dementia (VaD), Frontotemporal dementia (FTD), and Diffuse Dementia with Lewy Bodies (DLB). The diagnoses of FTD and DLB were according to Neary et al. [25] and McKeith et al. [26], respectively. The other diagnoses followed the ICD-10 criteria (the 10th revision of the International Statistical Classification of Diseases and Related Health Problems)
2.3. Statistics
3. Results
3.1. Person Characteristics
3.2. Comorbidity
3.3. Analyses of Blood and Cerebrospinal Fluid and Genetic Tests
3.4. Clinical Evaluation and Final Diagnosis
3.5. Independent Predictors of Fall Injuries
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sturnieks, D.L.; Chan, L.L.; Cerda, M.T.E.; Arbona, C.H.; Pinilla, B.H.; Martinez, P.S.; Seng, N.W.; Smith, N.; Menant, J.C.; Lord, S.R. Cognitive functioning and falls in older people: A systematic review and meta-analysis. Arch. Gerontol. Geriatr. 2024, 128, 105638. [Google Scholar] [CrossRef] [PubMed]
- Hollinghurst, R.; Williams, N.; Pedrick-Case, R.; North, L.; Long, S.; Fry, R.; Hollinghurst, J. Annual risk of falls resulting in emergency department and hospital attendances for older people: An observational study of 781,081 individuals living in Wales (United Kingdom) including deprivation, frailty and dementia diagnoses between 2010 and 2020. Age Ageing 2022, 51, afac176. [Google Scholar] [CrossRef] [PubMed]
- Masud, T.; Morris, R.O. Epidemiology of falls. Age Ageing 2001, 30 (Suppl. 4), 3–7. [Google Scholar] [CrossRef]
- Allan, L.M.; Ballard, C.G.; Rowan, E.N.; Kenny, R.A. Incidence and prediction of falls in dementia: A prospective study in older people. PLoS ONE 2009, 4, e5521. [Google Scholar] [CrossRef]
- Vos, T.; Lim, S.S.; Abbafati, C.; Abbas, K.M.; Abbasi, M.; Abbasifard, M.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Allah, F.; Abdelalim, A.; et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1204–1222. [Google Scholar] [CrossRef]
- Kinge, J.M.; Dieleman, J.L.; Karlstad, O.; Knudsen, A.K.; Klitkou, S.T.; Hay, S.I.; Vos, T.; Murray, C.J.L.; Vollset, S.E. Disease-specific health spending by age, sex, and type of care in Norway: A national health registry study. BMC Med. 2023, 21, 201. [Google Scholar] [CrossRef]
- Farup, P.G.; Hestad, K.; Engedal, K. Falls in Persons with Cognitive Impairment-Incidence and Characteristics of the Fallers. Geriatrics 2024, 9, 168. [Google Scholar] [CrossRef] [PubMed]
- Medboen, I.T.; Persson, K.; Navik, M.; Totland, T.H.; Bergh, S.; Trevino, C.S.; Ulstein, I.; Engedal, K.; Knapskog, A.B.; Braekhus, A.; et al. Cohort profile: The Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog)—A national research and quality registry with a biomaterial collection. BMJ Open 2022, 12, e058810. [Google Scholar] [CrossRef]
- Cesari, M. Role of gait speed in the assessment of older patients. JAMA 2011, 305, 93–94. [Google Scholar] [CrossRef]
- Guralnik, J.M.; Simonsick, E.M.; Ferrucci, L.; Glynn, R.J.; Berkman, L.F.; Blazer, D.G.; Scherr, P.A.; Wallace, R.B. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J. Gerontol. 1994, 49, M85–M94. [Google Scholar] [CrossRef]
- Vereeck, L.; Wuyts, F.; Truijen, S.; Van de Heyning, P. Clinical assessment of balance: Normative data, and gender and age effects. Int. J. Audiol. 2008, 47, 67–75. [Google Scholar] [CrossRef] [PubMed]
- Lawton, M.P.; Brody, E.M. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9, 179–186. [Google Scholar] [CrossRef] [PubMed]
- Hokoishi, K.; Ikeda, M.; Maki, N.; Nomura, M.; Torikawa, S.; Fujimoto, N.; Fukuhara, R.; Komori, K.; Tanabe, H. Interrater reliability of the Physical Self-Maintenance Scale and the Instrumental Activities of Daily Living Scale in a variety of health professional representatives. Aging Ment. Health 2001, 5, 38–40. [Google Scholar] [CrossRef] [PubMed]
- Alexopoulos, G.S.; Abrams, R.C.; Young, R.C.; Shamoian, C.A. Cornell Scale for Depression in Dementia. Biol. Psychiatry 1988, 23, 271–284. [Google Scholar] [CrossRef]
- Boeve, B.F.; Molano, J.R.; Ferman, T.J.; Smith, G.E.; Lin, S.C.; Bieniek, K.; Haidar, W.; Tippmann-Peikert, M.; Knopman, D.S.; Graff-Radford, N.R.; et al. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med. 2011, 12, 445–453. [Google Scholar] [CrossRef]
- Ferman, T.J.; Smith, G.E.; Boeve, B.F.; Ivnik, R.J.; Petersen, R.C.; Knopman, D.; Graff-Radford, N.; Parisi, J.; Dickson, D.W. DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004, 62, 181–187. [Google Scholar] [CrossRef]
- Creavin, S.T.; Wisniewski, S.; Noel-Storr, A.H.; Trevelyan, C.M.; Hampton, T.; Rayment, D.; Thom, V.M.; Nash, K.J.; Elhamoui, H.; Milligan, R.; et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst. Rev. 2016, 2016, CD011145. [Google Scholar] [CrossRef]
- Engedal, K.; Benth, J.S.; Gjora, L.; Skjellegrind, H.K.; Navik, M.; Selbaek, G. Normative Scores on the Norwegian Version of the Mini-Mental State Examination. J. Alzheimer’s Dis. 2023, 92, 831–842. [Google Scholar] [CrossRef]
- Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. Consortium to establish a registry for Alzheimer’s disease (CERAD) clinical and neuropsychological assessment of Alzheimer’s disease. Psychopharmacol. Bull. 1988, 24, 641–652. [Google Scholar]
- Kirsebom, B.E.; Espenes, R.; Hessen, E.; Waterloo, K.; Johnsen, S.H.; Gundersen, E.; Botne Sando, S.; Rolfseng Grontvedt, G.; Timon, S.; Fladby, T. Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years. Clin. Neuropsychol. 2019, 33, 27–39. [Google Scholar] [CrossRef]
- Wagle, J.; Selbaek, G.; Benth, J.S.; Gjora, L.; Ronqvist, T.K.; Bekkhus-Wetterberg, P.; Persson, K.; Engedal, K. The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study. J. Alzheimer’s Dis. 2023, 91, 321–343. [Google Scholar] [CrossRef] [PubMed]
- Knapskog, A.B.; Eldholm, R.S.; Braekhus, A.; Engedal, K.; Saltvedt, I. Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients. BMC Geriatr. 2017, 17, 210. [Google Scholar] [CrossRef]
- Jessen, F.; Amariglio, R.E.; van Boxtel, M.; Breteler, M.; Ceccaldi, M.; Chetelat, G.; Dubois, B.; Dufouil, C.; Ellis, K.A.; van der Flier, W.M.; et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s Dement. 2014, 10, 844–852. [Google Scholar] [CrossRef]
- Winblad, B.; Palmer, K.; Kivipelto, M.; Jelic, V.; Fratiglioni, L.; Wahlund, L.O.; Nordberg, A.; Backman, L.; Albert, M.; Almkvist, O.; et al. Mild cognitive impairment—beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004, 256, 240–246. [Google Scholar] [CrossRef]
- Neary, D.; Snowden, J.S.; Gustafson, L.; Passant, U.; Stuss, D.; Black, S.; Freedman, M.; Kertesz, A.; Robert, P.H.; Albert, M.; et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998, 51, 1546–1554. [Google Scholar] [CrossRef] [PubMed]
- McKeith, I.G.; Dickson, D.W.; Lowe, J.; Emre, M.; O’Brie n, J.T.; Feldman, H.; Cummings, J.; Duda, J.E.; Lippa, C.; Perry, E.K.; et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005, 65, 1863–1872. [Google Scholar] [CrossRef] [PubMed]
- Suominen, M.H.; Puranen, T.M.; Jyvakorpi, S.K.; Eloniemi-Sulkava, U.; Kautiainen, H.; Siljamaki-Ojansuu, U.; Pitkala, K.H. Nutritional Guidance Improves Nutrient Intake and Quality of Life, and May Prevent Falls in Aged Persons with Alzheimer Disease Living with a Spouse (NuAD Trial). J. Nutr. Health Aging 2015, 19, 901–907. [Google Scholar] [CrossRef]
- Minta, K.; Colombo, G.; Taylor, W.R.; Schinazi, V.R. Differences in fall-related characteristics across cognitive disorders. Front. Aging Neurosci. 2023, 15, 1171306. [Google Scholar] [CrossRef]
- Imamura, T.; Hirono, N.; Hashimoto, M.; Kazui, H.; Tanimukai, S.; Hanihara, T.; Takahara, A.; Mori, E. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer’s disease. Eur. J. Neurol. 2000, 7, 77–79. [Google Scholar] [CrossRef]
Variable | Number | Fall w/Injury | Fall wo/Injury | Statistics p-Value |
---|---|---|---|---|
Gender: Male Female | 1778 1996 | 366 (20.6%) 518 (26.0%) | 1412 (79.4%) 1478 (74.0%) | p < 0.001 |
Age (year) | 3774 | 77.4 (8.2) | 75.9 (8.6) | p < 0.001 |
BMI (kg/m2) | 3083 | 25.2 (4.5) | 25.9 (4.8) | p = 0.002 |
Education (year) | 3497 | 10.5 (3.4) | 10.8 (3.5) | p = 0.063 |
Living alone at home: Yes No | 1554 2115 | 414 (26.6%) 438 (20.7%) | 1140 (73.4%) 1677 (79.3%) | p < 0.001 |
Need for public health service: Yes No | 1750 1930 | 527 (30.1%) 340 (17.6%) | 1223 (69.9%) 1590 (82.4%) | p < 0.001 |
Walking assistance: No Indoor or outdoor Both in- and outdoor | 1518 393 624 | 282 (18.6%) 104 (26.5%) 221 (35.4%) | 1236 (81.4) 289 (73.5%) 403 (64.6%) | Trend: p < 0.001 |
Physical activity (score 0–8) | 3226 | 2.48 (2.27) | 2.87 (2.42) | p < 0.001 |
SPPB Walking (order 0–4) | 1625 | 2.82 (1.13) | 3.13 (1.02) | p < 0.001 |
SPPB Balance (seconds) | 796 | 6.12 (5.43) | 6.61 (6.18) | p = 0.378 |
PADL (score 6–30) | 3595 | 9.70 (4.09) | 8.59 (3.32) | p < 0.001 |
IADL (score 8–31) | 3652 | 17.40 (6.40) | 15.96 (6.12) | p < 0.001 |
Blood pressure (syst.) sitting (mmHg) | 3214 | 143.4 (24.5) | 144.4 (22.8) | p = 0.316 |
Blood pressure (diastolic) sitting | 3213 | 80.9 (13.6) | 81.3 (12.3) | p = 0.376 |
Heart rate sitting (beats/min) | 3175 | 74.5 (15.0) | 73.3 (13.6) | p = 0.036 |
Blood pressure (systolic) standing 1 min | 2606 | 138.6 (25.5) | 138.8 (24.8) | p = 0.864 |
Blood pressure (diastolic) standing 1 min | 2603 | 80.5 (14.4) | 80.6 (18.9) | p = 0.896 |
Heart rate standing 1 min | 2552 | 80.5 (15.4) | 78.5 (14.7) | p = 0.005 |
Blood pressure (systolic) standing 3 min | 2491 | 143.2 (25.9) | 142.3 (24.5) | p = 0.482 |
Blood pressure (diastolic) standing 3 min | 2487 | 82.5 (14.3) | 82.2 (13.5) | p = 0.661 |
Heart rate standing 3 min | 1902 | 82.1 (42.2) | 78.5 (14.8) | p = 0.005 |
Variable | Number | Fall w/Injury | Fall wo/Injury | Statistics p-Value |
---|---|---|---|---|
Cerebrovascular disease: Yes No | 1007 2767 | 288 (28.6%) 596 (21.5%) | 719 (71.4%) 2171 (78.5%) | p < 0.001 |
Parkinson’s disease: Yes No | 199 3575 | 36 (18.1%) 848 (23.7%) | 163 (81.9%) 2727 (76.3%) | p = 0.071 |
Neurological disease: Yes No | 711 3063 | 180 (25.3%) 704 (23.0%) | 531 (74.7%) 2359 (77.0%) | p = 0.185 |
Coronary heart disease: Yes No | 2264 1510 | 562 (24.8%) 322 (21.3%) | 1702 (75.2%) 1188 (78.7%) | p = 0.013 |
Cardiac surgery: Yes No | 171 3603 | 38 (22.2%) 846 (23.5%) | 133 (77.8%) 2757 (76.5%) | p = 0.782 |
Diabetes: Yes No | 606 3168 | 147 (24.3%) 737 (23.3%) | 459 (75.7%) 2431 (76.7%) | p = 0.601 |
Cancer: Yes No | 454 3320 | 85 (18.7%) 799 (24.1%) | 369 (81.3%) 2521 (75.9%) | p = 0.011 |
COPD: Yes No | 306 3468 | 92 (30.1%) 792 (22.8%) | 214 (69.9%) 2676 (77.2%) | p = 0.006 |
Polyarthritis: Yes No | 210 3564 | 45 (21.4%) 839 (23.5%) | 165 (78.6%) 2725 (76.5%) | p = 0.557 |
Depression (actual) Yes No | 439 3335 | 102 (23.2%) 782 (23.4%) | 337 (76.8%) 2553 (76.6% | p = 0.952 |
Cornell depression (scale 0–38) | 2627 | 7.85 (5.88) | 7.49 (5.96) | p = 0.200 |
MAYO Sleep (scale 0–10) | 721 | 6.88 (2.38) | 7.25 (2.35) | p = 0.075 |
MAYO Fluctuation (scale 0–4) | 1439 | 1.62 (1.28) | 1.59 (1.24) | p = 0.708 |
MAYO Fluctuation: Normal (score < 3) Abnormal (score ≥ 3) | 1083 356 | 242 (22.3%) 86 (24.2%) | 841 (77.7%) 270 (75.8%) | p = 0.512 |
Duration of cognitive impairment (years) | 2345 | 3.16 (3.23) | 3.33 (3.67) | p = 0.328 |
MMSE-NR3 (score 0–30) | 2927 | 22.58 (4.65) | 23.00 (4.61) | p = 0.038 |
CERAD–Immediate recall | 3086 | 11.69 (4.86) | 11.89 (4.94) | p = 0.345 |
CERAD–delayed recall | 3043 | 2.21 (2.19) | 2.30 (2.22) | p = 0.304 |
TMT-A (seconds) | 3251 | 102.8 (64.7) | 97.1 (64.6) | p = 0.033 |
TMT-B (seconds) | 1563 | 214.3 (102.6) | 202.9 (108.0) | p = 0.079 |
Drugs (number) | 2511 | 5.67 (3.27) | 5.04 (3.41) | p < 0.001 |
Number | Fall w/Injury | Fall wo/Injury | Statistics p-Value | |
---|---|---|---|---|
Blood tests | ||||
Hb (g/100 mL) | 2716 | 13.3 (1.8) | 13.7 (1.7) | p < 0.001 |
CRP (mg/L) | 2461 | 5.9 (11.5) | 5.3 (9.6) | p = 0.245 |
ESR (mm/1 h) | 1510 | 17.0 (17.1) | 14.0 (14.6) | p = 0.003 |
Thrombocytes (109/L) | 2517 | 255 (88) | 247 (74) | p = 0.036 |
Creatinine (µmol/L) | 2744 | 87.8 (42.8) | 86.3 (41.1) | p = 0.404 |
Albumin (g/L) | 2513 | 40.8 (5.1) | 41.8 (13.1) | p = 0.062 |
Folic acid (nmol/L) | 2320 | 20.9 (14.9) | 20.1 (14.5) | p = 0.259 |
Cholesterol (mmol/L) | 2170 | 5.0 (2.2) | 5.0 (1.8) | p = 0.512 |
Homocysteine (µmol/L) | 1553 | 16.9 (6.9) | 15.8 (6.6) | p = 0.005 |
Na (mmol/L) | 2706 | 140.2 (3.0) | 140.6 (3.0) | p = 0.017 |
K (mmol/L) | 2710 | 4.3 (0.5) | 4.3 (0.4) | p = 0.853 |
Ca (mmol/L) | 2146 | 2.23 (0.41) | 2.29 (0.34) | p = 0.004 |
Thyroxin (pmol/L) | 2439 | 15.6 (3.1) | 15.6 (4.2) | p = 0.901 |
TSH (mU/L) | 2585 | 1.89 (1.23) | 1.86 (1.20) | p = 0.559 |
Vitamin B12 (pmol/L) | 2568 | 400 (282) | 388 (270) | p = 0.317 |
Vitamin D (nmol/L) | 665 | 74.3 (31.3) | 71.9 (26.8) | p = 0.401 |
HbA1c (mmol/mol) | 610 | 42.3 (13.2) | 42.0 (11.4) | p = 0.776 |
Methyl Malonate (µmol/L) | 878 | 0.25 (0.14) | 0.24 (0.26) | p = 0.787 |
ALAT (U/L) | 2664 | 21.5 (16.9) | 21.9 (12.8) | p = 0.533 |
Gamma-GT (U/L) | 1778 | 49.4 (77.1) | 40.8 (48.8) | p = 0.033 |
ALP (U/L) | 2339 | 79.7 (39.3) | 76.8 (33.9) | p = 0.096 |
Spinal fluid | ||||
Phospho-tau (pg/mL) | 444 | 57.3 (33.7) | 67.4 (43.5) | p = 0.047 |
Total-tau (pg/mL) | 445 | 434 (299) | 481 (300) | p = 0.098 |
Beta-amyloid (ng/L) | 445 | 737 (320) | 751 (329) | p = 0.742 |
Genes | 545 | |||
APOE E2E2 | 1 | 1 (100%) | 0 (0%) | Chi- |
APOE E2E3 | 33 | 5 (15%) | 28 (85%) | square |
APOE E2E4 | 18 | 4 (22%) | 14 (78%) | Pearson |
APOE E3E3 | 237 | 50 (21%) | 187 (79%) | p = 0.390 |
APOE E3E4 | 204 | 38 (19%) | 166 (81%) | Lin-by-lin * |
APOE E4E4 | 52 | 12 (23%) | 40 (77%) | p = 0.964 |
Variable | Number | Fall w/Injury | Fall wo/Injury | Statistics p-Value |
---|---|---|---|---|
Clinical impairment
-SCI -MCI -Dementia | 3026 181 1144 1701 | 36 (19.9%) 269 (23.5%) 406 (23.9%) | 145 (80.1%) 875 (76.5%) 1295 (76.1%) | Pearson p = 0.486 Lin-by-Lin * p = 0.365 |
Dementia diagnoses: AD AD/VaD VaD FTD DLB | 537 240 126 115 12 44 | 47 (19.6) 39 31.0%) 31 (27.0%) 3 (25.0%) 8 (18.2%) | 193 (80.4%) 87 (69.0%) 84 (73.0%) 9 (75.0%) 36 (81.8%) | Pearson p = 0.121 |
Dependent Variables | B | Wald | OR | 95% CI | p-Value |
---|---|---|---|---|---|
Sex (male) | −0.074 | 0.294 | 0.929 | 0.712; 1.212 | p =0.588 |
Age (years) | −0.018 | 3.861 | 0.982 | 0.965; 1.000 | p = 0.049 |
BMI (kg/m2) | −0.047 | 10.304 | 0.954 | 0.927; 0.982 | p = 0.001 |
Public health service | 0.445 | 9.535 | 1.561 | 1.177; 2.071 | p = 0.002 |
Walking assistance | 0.366 | 18.601 | 1.443 | 1.221; 1.702 | p < 0.001 |
Serum-Ca (mmol/L) | −0.450 | 6.764 | 0.637 | 0.454; 0.895 | p = 0.009 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Farup, P.G.; Hestad, K.; Engedal, K. Predictors of Fall-Related Injuries in Fallers—A Study in Persons with Cognitive Impairment. Geriatrics 2025, 10, 74. https://doi.org/10.3390/geriatrics10030074
Farup PG, Hestad K, Engedal K. Predictors of Fall-Related Injuries in Fallers—A Study in Persons with Cognitive Impairment. Geriatrics. 2025; 10(3):74. https://doi.org/10.3390/geriatrics10030074
Chicago/Turabian StyleFarup, Per G., Knut Hestad, and Knut Engedal. 2025. "Predictors of Fall-Related Injuries in Fallers—A Study in Persons with Cognitive Impairment" Geriatrics 10, no. 3: 74. https://doi.org/10.3390/geriatrics10030074
APA StyleFarup, P. G., Hestad, K., & Engedal, K. (2025). Predictors of Fall-Related Injuries in Fallers—A Study in Persons with Cognitive Impairment. Geriatrics, 10(3), 74. https://doi.org/10.3390/geriatrics10030074